Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia.
- Citation:
- Yakout, T., M. E. M. Gammal, A. Elias, and O. Khoreshid,
"Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia. ",
ASCO 2013, USA, 5/2013.
Date Presented:
5/2013
